Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918283 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
VMAT should be considered as a safe, alternative modality to GK for VS SRS treatment, especially for tumors larger than 0.5Â cm3.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hyun Kim, Peter Potrebko, Amanda Rivera, Haisong Liu, Harriet B. Eldredge-Hindy, Vickie Gunn, Maria Werner-Wasik, David W. Andrews, James J. Evans, Christopher J. Farrell, Kevin Judy, Wenyin Shi,